Michele Holcomb has over 25 years of experience in the healthcare industry as a scientist, strategist, and global leader of business development and R&D. She brings a broad knowledge of the healthcare ecosystem, across pharmaceutical companies, payors, providers, pharmacies, and the dynamics among them. She has worked with companies at all stages of pharmaceutical development and with companies in healthcare services.

Holcomb’s experience includes most recently serving as the Chief Strategy and Business Development Officer at Cardinal Health where she worked with business leaders to develop strategy and identify opportunities for innovation and growth. Her team also led the execution and integration of acquisitions, partnerships and divestitures.

Holcomb came to Cardinal Health from Teva Pharmaceuticals where she held roles in R&D and Strategy. Her roles included COO of Global R&D and SVP of Strategy, Portfolio, Search and Partnerships, and VP of Corporate Strategy.

Prior to Teva, she was a partner in the Global Pharmaceutical Practice at McKinsey & Company, where she spent 15 years. She served 6 of the top 10 global pharmaceutical companies, as well as high-growth biotechs and mid-cap pharmaceutical companies.

Holcomb is a member of the board of directors and audit committees of Kimball Electronics Inc. She also serves on the board of the Abigail Wexner Research Institute at Nationwide Children’s Hospital in Columbus and BalletMet of Columbus, where she chairs the long-range planning committee. Holcomb is a member of the editorial advisory board of Pharmaceutical Executive and has lectured on healthcare strategy at Kellogg (Northwestern), Columbia and Fuqua (Duke) business schools. While at Cardinal Health, she led the Women’s Impact Network at Cardinal Health and served on the board of rev1, an incubator and investor in innovation and supporter of entrepreneurs in Columbus, Ohio.

Holcomb is trained as a chemist, with a BS in chemistry from Stanford University, a PhD in Chemistry from the University of California, Berkeley, and experience as a bench chemist at Syntex Pharmaceuticals and Ciba-Geigy.